Table 1

HIV prevalence among women attending termination of pregnancy (TOP) services

Authors, publication yearPublication typeGeographical locationStudy periodTotal participants, n (TOP/delivery)Overall HIV prevalence in TOP (%)Prevalence of new HIV infections in TOP (%)HIV prevalence in women delivering (%)HIV prevalence in general population* (%)
Unlinked anonymous testing studies
Goldberg et al, 199221ArticleDundee, Scotland1988–19906228 (1535/4693)0.850.13
Couturier et al, 199217ArticleParis, France1990–199111 593 (2718/7261)0.70.28
Obadia et al, 199418ArticleFrance (Southeast)1991–199211 056 (2298/7301)0.560.22
Remis et al, 199523ArticleMontreal, Canada1989–199312 0170.180.21
Abeni et al, 199719ArticleRome, Italy1989–1994218 357 (61 777/138 359)0.490.18
Goldberg et al, 200034ArticleDundee, Scotland1993–199717 899 (4650/13 249)0.150.11
Drey et al, 200524ArticleSan Francisco, USA2002–200319920.55
Thornton et al, 200722AbstractLondon, UK2005Not available1.010.44
Carnicer-Pont et al, 201120ArticleCatalonia, Spain1999–2006581 593 (31 904/549 689)0.130.18
Routine testing studies†
Crowe, 200826AbstractLondon, UK2003–200716180.770.45
Creighton et al, 200925AbstractLondon, UK2008699‡0.6
Garrard et al, 201028AbstractLondon, UK2008–20092831‡0.52
Rosenvinge et al, 201027AbstractLondon, UK20098440.56
Creighton et al, 201231LetterLondon, UK2008–201143260.820.30.8
  • Articles are listed in chronological order of publication.

  • Created by the authors.

  • *Measured in the same geographical region and period.

  • †For routine testing studies, the number of participants refers to the number of women offered HIV testing in TOP settings whether they accepted or declined testing; prevalence refers to the proportion of participants who tested positive for HIV infection out of the participants who accepted HIV testing.

  • ‡Opt-out testing.